NDC 68682-464

BRINZOLAMIDE

Brinzolamide

BRINZOLAMIDE is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Oceanside Pharmaceuticals.. The primary component is Brinzolamide.

Product ID68682-464_fb7229d4-522e-4cb2-b513-9d34f3ded591
NDC68682-464
Product TypeHuman Prescription Drug
Proprietary NameBRINZOLAMIDE
Generic NameBrinzolamide
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-08-25
Marketing CategoryANDA /
Application NumberANDA204884
Labeler NameOceanside Pharmaceuticals.
Substance NameBRINZOLAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68682-464-10

1 BOTTLE, PLASTIC in 1 CARTON (68682-464-10) > 10 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2021-08-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "BRINZOLAMIDE" or generic name "Brinzolamide"

NDCBrand NameGeneric Name
0591-2127BrinzolamideBrinzolamide
0781-6014BrinzolamideBrinzolamide
24208-464BRINZOLAMIDEbrinzolamide
63629-8793BrinzolamideBrinzolamide
68682-464BRINZOLAMIDEbrinzolamide
0065-0275Azoptbrinzolamide
0078-0722Azoptbrinzolamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.